IN.PACT™ ADMIRAL™ DRUG-COATED BALLOON

IN.PACT™ ADMIRAL™ DRUG COATED BALLOON

Maintain long-term vessel patency with the IN.PACT™ Admiral™ drug-coated balloon, the market-leading DCB for treatment of femoropopliteal disease with 75% of patients reintervention-free at 5 years.1

Physician Perspective on IN.PACT Admiral DCB - (02:54)

Watch to learn why IN.PACT Admiral is Dr. Ehrin Armstrong's DCB of choice.
More information (see more) Less information (see less)

IN.PACT Admiral DCB Overview Video - (03:11)

Watch video to learn more about the IN.PACT Admiral DCB's product details, clinical evidence, and patient benefit.
More information (see more) Less information (see less)

pdf IN.PACT Admiral Drug-Coated Balloon 5-Year Reintervention Free Flyer (.pdf)

Learn more about IN.PACT Admiral drug-coated balloon.

381KB

pdf IN.PACT Admiral Drug-Coated Balloon Class of its Own Sell Sheet (.pdf)

See how IN.PACT Admiral drug-coated balloon shows two times the patency benefit at one year compared to PTA.

140KB

pdf IN.PACT Admiral Drug-Coated Balloon 5-Year Reintervention Free Ad (.pdf)

See how IN.PACT Admiral drug-coated balloon compares with other DCBs on patency benefit and CD-TLR rates.

2.0MB

FIND MORE ON IN.PACT ADMIRAL DRUG-COATED BALLOON

Visit

DON'T MISS A MOMENT

Explore our SIR 2021 events schedule.

SEE EVENT LINEUP
CONTACT

Would you like to learn more about Medtronic products?

Contact us
1

Laird J, Schneider P, Jaff MR, et al. Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions. 5-year results from the IN.PACT SFA Trial. Circ Cardiovasc Interv. June 2019;12(6):e007702.